We are live on ! Find out more
DFTX

Definium Therapeutics
DFTX

174 hedge funds and large institutions have $105M invested in Definium Therapeutics in 2021 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 54 increasing their positions, 34 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

129% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 17

59% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 34

18% more call options, than puts

Call options by funds: $7.82M | Put options by funds: $6.62M

12% more funds holding

Funds holding: 155 → 174 (+19)

0.13% more ownership

Funds ownership: 0.74% → 0.87% (+0.13%)

20% less capital invested

Capital invested by funds: $130M → $105M (-$25.5M)

Holders
174
Holders Change
+19
Holders Change %
+12.26%
% of All Funds
3.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
39
Increased
54
Reduced
34
Closed
17
Calls
$7.82M
Puts
$6.62M
Net Calls
+$1.21M
Net Calls Change
-$1.76M

Top Buyers

1
Northern Trust
Northern Trust
Illinois
+$6.83M
2
State Street
State Street
Massachusetts
+$3.34M
3
BlackRock
BlackRock
New York
+$2.87M
4
BB
Busey Bank
Illinois
+$2.35M
5
Goldman Sachs
Goldman Sachs
New York
+$2.14M

Top Sellers

1
Jane Street
Jane Street
New York
-$1.65M
2
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS)
California
-$737K
3
UBS AM
UBS AM
Illinois
-$567K
4
VF
Virtu Financial
New York
-$564K
5
JP Morgan Chase
JP Morgan Chase
New York
-$532K
Name Holding Trade Value Shares
Change 		Change in
Stake
AFG
126
Albion Financial Group
Utah
$11K – – –
WQ
127
Wealth Quarterback
New Jersey
$11K +$432 +10 +3%
FIA
128
FNY Investment Advisers
New York
$9K -$107K -2,486 -90%
GKWIM
129
Gerber Kawasaki Wealth & Investment Management
California
$9K -$49K -1,133 -100%
CAPTRUST Financial Advisors
130
CAPTRUST Financial Advisors
North Carolina
$9K +$43 +1 +0.4%
SIM
131
Sonora Investment Management
Arizona
$8K – – –
CA
132
Clearstead Advisors
Ohio
$8K +$432 +10 +5%
KTC
133
Kistler-Tiffany Companies
Pennsylvania
$8K +$9.43K +218 New
SPIA
134
Steward Partners Investment Advisory
New York
$6K – – –
GWS
135
Glassman Wealth Services
Virginia
$6K +$7.22K +167 New
Rockefeller Capital Management
136
Rockefeller Capital Management
New York
$5K -$432 -10 -6%
BAM
137
Baldrige Asset Management
Pennsylvania
$5K – – –
FRA
138
Front Row Advisors
California
$5K – – –
PNC Financial Services Group
139
PNC Financial Services Group
Pennsylvania
$5K – – –
US Bancorp
140
US Bancorp
Minnesota
$5K +$5.75K +133 New
MAM
141
Meeder Asset Management
Ohio
$4K +$6.05K +140 New
BC
142
Burleson & Co
California
$3K +$865 +20 +30%
HI
143
Harbour Investments
Wisconsin
$2K -$3.93K -91 -64%
ARMC
144
American Research & Management Company
Massachusetts
$2K – – –
AF
145
Arrow Financial
New York
$2K – – –
TFM
146
TFC Financial Management
Massachusetts
$2K – – –
TCM
147
Tradewinds Capital Management
Washington
$2K – – –
Northwestern Mutual Wealth Management
148
Northwestern Mutual Wealth Management
Wisconsin
$2K +$2.08K +48 New
BCV
149
Banque Cantonale Vaudoise
Switzerland
$2K +$2.21K +51 New
UBS Group
150
UBS Group
Switzerland
$2K +$2.29K +53 +312%
4 5
6
7 8

DFTX Hedge Fund Activity: Q3 2021 in Review

174 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Definium Therapeutics (DFTX) for Q3 2021, worth a combined $105M — down 20% from $130M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new DFTX positions and 17 closed out — a net gain of 22 holders — while 54 added to existing stakes and 34 trimmed.

The largest buyer was Northern Trust, adding an estimated $6.83M. The largest seller was Jane Street, cutting an estimated $1.65M.

  • 174 institutional investors held Definium Therapeutics (DFTX) as of Q3 2021, up from 155 in Q2 2021.
  • Funds reported $105M of Definium Therapeutics stock for Q3 2021, down 20% quarter-over-quarter.
  • 39 funds opened new Definium Therapeutics positions in Q3 2021 and 17 closed out, a net change of +22 holders.
  • The largest Definium Therapeutics buyer in Q3 2021 was Northern Trust, an estimated $6.83M added.
  • The largest Definium Therapeutics seller in Q3 2021 was Jane Street, an estimated $1.65M sold.

Based on aggregated 13F filings for Q3 2021.